Show items per page
Elements: 113
Page 1 on 3
 TitleAuthors / EditorsDate
add to browser selection
Early and prolonged decrease of viremia in HIV-1-infected patients treated with didanosine Yerly Ferrillo, Sabine; Kaiser, Laurent; Baumberger, C.; Hirschel, Bernard; Perrin, Luc 1995
add to browser selection
Controversies: does the CD4+ cell count reflect clinical efficacy? Kinloch-de-Loes, S.; Perrin, L. H.; Hirschel, Bernard; Perneger, T. V. 1996
add to browser selection
Infection VIH, tuberculose et test tuberculinique en Suisse. The Swiss HIV Cohort Study Sudre, Philippe; Rieder, H.; Bassetti, S.; Hirschel, Bernard; ... Malvy, D. 1996
add to browser selection
Predictive value of codon 215 reverse transcriptase mutation on the efficacy of didanosine in HIV-infected, zidovudine-experienced patients Yerly Ferrillo, Sabine; Denereaz, N.; Mermillod, Bernadette; Hirschel, Bernard; Perrin, Luc 1996
add to browser selection
Combined therapy with zidovudine and L-697,661 in primary HIV infection Perrin, Luc; Rakik, A.; Yerly Ferrillo, Sabine; Baumberger, Christophe; ... Hirschel, Bernard 1996
add to browser selection
Prognostic value of viremia in patients with long-standing human immunodeficiency virus infection. Swiss HIV Cohort Study Group Galetto-Lacour, Annick; Yerly Ferrillo, Sabine; Perneger, T. V.; Baumberger, Christophe; ... Perrin, Luc 1996
add to browser selection
Chemotherapy for AIDS-related malignancies does not increase HIV viraemia Rutschmann, Olivier Thierry; Pechere, Marc; Krischer, J.; Perrin, Luc; Hirschel, Bernard 1997
add to browser selection
Cytomegalovirus retinitis: decreased risk of bilaterality with increased use of systemic treatment. Swiss HIV Cohort Study Group Stalder, N.; Sudre, Philippe; Olmari, M.; Opravil, M.; ... Hirschel, Bernard 1997
add to browser selection
Toxicity, efficacy, plasma drug concentrations and protease mutations in patients with advanced HIV infection treated with ritonavir plus saquinavir. Swiss HIV Cohort Study Lorenzi, P.; Yerly Ferrillo, Sabine; Abderrakim, K.; Fathi, Marc; ... Hirschel, Bernard 1997
add to browser selection
Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study. Swiss HIV Cohort Study Egger, M.; Hirschel, Bernard; Francioli, Patrick; Sudre, Philippe; ... Battegay, M. 1997
add to browser selection
Survival in 2367 zidovudine-treated patients according to use of other nucleoside analogue drugs. The EuroSIDA Study Group Phillips, A. N.; Katlama, C.; Barton, S.; Vella, S.; ... Lundgren, J. D. 1998
add to browser selection
Didanosine plus stavudine with or without hydroxyurea in HIV-1-infected patients: 1 year follow-up. Swiss HIV Cohort Study Rutschmann, Olivier Thierry; Opravil, M.; Iten, A.; Malinverni, R.; ... Hirschel, Bernard 1998
add to browser selection
Colour vision in AIDS patients without HIV retinopathy Sommerhalder, Jorg; Baglivo, Edoardo; Barbey, Catherine; Hirschel, Bernard; ... Pelizzone, Marco 1998
add to browser selection
A randomized double-blind controlled study of 6 months of oral nutritional supplementation with arginine and omega-3 fatty acids in HIV-infected patients. Swiss HIV Cohort Study Pichard, Claude; Sudre, Philippe; Karsegard, V.; Yerly Ferrillo, Sabine; ... Hirschel, Bernard 1998
add to browser selection
A placebo-controlled trial of didanosine plus stavudine, with and without hydroxyurea, for HIV infection. The Swiss HIV Cohort Study Rutschmann, Olivier Thierry; Opravil, M.; Iten, A.; Malinverni, R.; ... Hirschel, Bernard 1998
add to browser selection
Turnover of CD4+ and CD8+ T lymphocytes in HIV-1 infection as measured by Ki-67 antigen Sachsenberg, N.; Perelson, A. S.; Yerly Ferrillo, Sabine; Schockmel, G. A.; ... Perrin, Luc 1998
add to browser selection
Regression of Kaposi's sarcoma during therapy with HIV-1 protease inhibitors: a prospective pilot study Krischer, Joachim; Rutschmann, Olivier Thierry; Hirschel, Bernard; Vollenweider-Roten, S.; ... Pechere, Marc 1998
add to browser selection
A critical assessment of the prognostic value of HIV-1 RNA levels and CD4+ cell counts in HIV-infected patients. The Swiss HIV Cohort Study Yerly Ferrillo, Sabine; Perneger, T. V.; Hirschel, Bernard; Dubuis, O.; ... Perrin, Luc 1998
add to browser selection
Preoperative counts of CD4 T-lymphocytes and early postoperative infective complications in HIV-positive patients Savioz, Daniel; Chilcott, Michael John; Ludwig, Corinna; Savioz, M; ... Morel, Philippe 1998
add to browser selection
Association between the rate of CD4+ T cell decrease and the year of human immunodeficiency virus (HIV) type 1 seroconversion among persons enrolled in the Swiss HIV cohort study Vanhems, P.; Lambert, J.; Guerra, M.; Hirschel, Bernard; Allard, Robert 1999
add to browser selection
A randomized, controlled trial of indinavir, zidovudine, and lamivudine in adults with advanced human immunodeficiency virus type 1 infection and prior antiretroviral therapy Hirsch, M.; Steigbigel, R.; Staszewski, S.; Mellors, J.; ... Leavitt, R. 1999
add to browser selection
AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study Ledergerber, Bruno; Egger, M.; Erard, V.; Weber, R.; ... Telenti, A. 1999
add to browser selection
Discontinuation of primary prophylaxis against Pneumocystis carinii pneumonia in HIV-1-infected adults treated with combination antiretroviral therapy. Swiss HIV Cohort Study Furrer, Hansjakob; Egger, M.; Opravil, M.; Bernasconi, Enos; ... Malinverni, R. 1999
add to browser selection
Incubation time of acute human immunodeficiency virus (HIV) infection and duration of acute HIV infection are independent prognostic factors of progression to AIDS Vanhems, P.; Hirschel, Bernard; Phillips, A. N.; Cooper, David; ... Perrin, Luc 2000
add to browser selection
Comparison of clinical features, CD4 and CD8 responses among patients with acute HIV-1 infection from Geneva, Seattle and Sydney Vanhems, P.; Hughes, J.; Collier, A. C.; Vizzard, J.; ... Hirschel, Bernard 2000
add to browser selection
Salvage therapy with abacavir plus a non-nucleoside reverse transcriptase inhibitor and a protease inhibitor in heavily pre-treated HIV-1 infected patients. Swiss HIV Cohort Study Khanna, Nina; Klimkait, T.; Schiffer, V.; Irigoyen, J.; ... Battegay, M. 2000
add to browser selection
Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study Greub, Gilbert; Ledergerber, Bruno; Battegay, M.; Grob, P.; ... Telenti, A. 2000
add to browser selection
Time of initiation of antiretroviral therapy: impact on HIV-1 viraemia. The Swiss HIV Cohort Study Yerly Ferrillo, Sabine; Kaiser, Laurent; Perneger, T. V.; Cone, R. W.; ... Perrin, Luc 2000
add to browser selection
Response to first protease inhibitor- and efavirenz-containing antiretroviral combination therapy. The Swiss HIV Cohort Study Friedl, A. C.; Ledergerber, Bruno; Flepp, Markus; Hirschel, Bernard; ... Weber, R. 2001
add to browser selection
Impact of occasional short interruptions of HAART on the progression of HIV infection: results from a cohort study Taffe, Patrick; Rickenbach, Martin; Hirschel, Bernard; Opravil, Milos; ... Sudre, Philippe 2002
add to browser selection
The CD4 cell count 3 months after acute retroviral syndrome is associated with the presence of AIDS in the source individual Vanhems, Philippe; Caillat-Vallet, Emmanuelle; Hirschel, Bernard; Routy, J. P.; ... Perrin, Luc 2002
add to browser selection
Clinical efficacy of early initiation of HAART in patients with asymptomatic HIV infection and CD4 cell count > 350 x 10(6) Opravil, Milos; Ledergerber, Bruno; Furrer, Hansjakob; Hirschel, Bernard; ... Weber, Rainer 2002
add to browser selection
Residual HIV-specific CD4 and CD8 T cell frequencies after prolonged antiretroviral therapy reflect pretreatment plasma virus load Oxenius, Annette; Price, D. A.; Dawson, S. J.; Gunthard, Huldrych; ... Phillips, R. E. 2002
add to browser selection
Stimulation of HIV-specific cellular immunity by structured treatment interruption fails to enhance viral control in chronic HIV infection Oxenius, Annette; Price, D. A.; Gunthard, Huldrych; Dawson, S. J.; ... Phillips, R. E. 2002
add to browser selection
Functional discrepancies in HIV-specific CD8+ T-lymphocyte populations are related to plasma virus load Oxenius, Annetie; Sewell, A. K.; Dawson, S. J.; Gunthard, Huldrych; ... Price, D. A. 2002
add to browser selection
Switching from protease inhibitors to efavirenz: differences in efficacy and tolerance among risk groups: a case-control study from the Swiss HIV Cohort Hirschel, Bernard; Flepp, Markus; Bucher, H. C.; Zellweger, Claudine; ... Ledergerber, Bruno 2002
add to browser selection
A patient with HIV-1 superinfection Jost, Stéphanie; Bernard, Marie-Charlotte; Kaiser, Laurent; Yerly Ferrillo, Sabine; ... Perrin, Luc 2002
add to browser selection
Response to antiretroviral therapy among patients exposed to three classes of antiretrovirals: results from the EuroSIDA study Mocroft, A.; Phillips, A. N.; Friis-Moller, N.; Colebunders, R.; ... Lundgren, J. D. 2002
add to browser selection
Ritonavir plus saquinavir versus single protease inhibitor therapy in protease inhibitor-naive HIV-infected patients: the Swiss HIV Cohort Study Bucher, H. C.; Bichsel, M.; Taffe, Patrick; Furrer, Hansjakob; ... Battegay, M. 2002
add to browser selection
Is autovaccination dead? Hirschel, Bernard 2003
add to browser selection
Structured treatment interruptions in HIV infection: benefit or disappointment? Oxenius, Annette; Hirschel, Bernard 2003
add to browser selection
Brief report: incubation and duration of specific symptoms at acute retroviral syndrome as independent predictors of progression to AIDS Vanhems, Philippe; Voirin, Nicolas; Hirschel, Bernard; Cooper, David; ... Perrin, Luc 2003
add to browser selection
Long-term efficacy, safety, and tolerability of indinavir-based therapy in protease inhibitor-naive adults with advanced HIV infection Hirsch, M. S.; Steigbigel, R. T.; Staszewski, Scholomo; McMahon, Deborah; ... Leavitt, R. Y. 2003
add to browser selection
Beware of drug holidays before HIV salvage therapy Hirschel, Bernard 2003
add to browser selection
CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study Kaufmann, G. R.; Perrin, Luc; Pantaleo, Guiseppe; Opravil, Milos; ... Battegay, Manuel 2003
add to browser selection
A controlled trial of granulocyte macrophage-colony stimulating factor during interruption of HAART Fagard, Catherine; Le Braz, Michelle; Gunthard, Huldrych; Hirsch, H. H.; ... Hirschel, Bernard 2003
add to browser selection
A prospective trial of structured treatment interruptions in human immunodeficiency virus infection Fagard, Catherine; Oxenius, Annette; Gunthard, Huldrych; Garcia, Felipe; ... Hirschel, Bernard 2003
add to browser selection
Relevance of HIV-1-specific CD4+ helper T-cell responses during structured treatment interruptions in patients with CD4+ T-cell nadir above 400/mm3 Plana, Montserrat; Garcia, Felipe; Oxenius, Annette; Ortiz, G. M.; ... Gatell, J. M. 2004
add to browser selection
L-ornithine alpha-ketoglutarate in HIV infection: effects on muscle, gastrointestinal, and immune functions Karsegard, V. L.; Raguso, C. A.; Genton Graf, Laurence; Hirschel, Bernard; Pichard, Claude 2004
add to browser selection
Treatment of psoriasis with alefacept in patients with hepatitis C infection: a report of two cases Thaci, Diamant; Patzold, S.; Kaufmann, Roland; Boehncke, Wolf-Henning 2005
<< previous | 1 | 2 | 3 |